Sorry...!!! You are not eligible for this website
Age Verification
You must be 21+ years old to visit our website. Select your preference below.
By entering this site you are agreeing to the Terms of Use and Privacy Policy.
You must be 21+ years old to visit our website. Select your preference below.
By entering this site you are agreeing to the Terms of Use and Privacy Policy.
$79.99
Important Disclaimer: This product is sold strictly for research and laboratory use only and is not intended for human or animal consumption, medical, diagnostic, or therapeutic purposes.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Combines two widely studied recovery-focused peptides in a single injectable research formulation
Supports investigation of tissue repair and remodeling signaling pathways
Commonly explored for inflammation response and post-stress recovery models
Injectable format allows controlled systemic delivery for research protocols
Frequently used in multi-pathway recovery and regeneration studies
The BPC-157 + TB-500 injectable blend is a combined research formulation designed for studies focused on tissue recovery, cellular repair signaling, and structural remodeling pathways.
BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a naturally occurring gastric protective protein fragment. In laboratory and pre-clinical research, it is commonly explored for its involvement in angiogenic signaling, nitric-oxide–related pathways, inflammatory response regulation, and overall tissue-integrity mechanisms.
TB-500 is a synthetic peptide modeled after the active region of thymosin beta-4 and is widely studied for its role in actin regulation, cellular migration, and cytoskeletal organization. These pathways are central to how cells move, reorganize, and coordinate repair during tissue remodeling.
Together, this injectable blend is frequently selected in research environments where investigators want to evaluate complementary recovery and regeneration pathways—pairing BPC-157’s tissue-protective and signaling activity with TB-500’s cellular movement and remodeling functions. The injectable format supports consistent systemic exposure for controlled and repeatable research applications.
Soft-tissue, tendon, ligament, and connective-tissue recovery models
Tissue repair, remodeling, and structural signaling pathways
Inflammatory response coordination and modulation research
Angiogenesis, microcirculation, and cellular migration studies
Physical stress and post-training recovery research models
